The partnership aims to provide sponsors and researchers with a complete solution for disclosure and data sharing.
TrialScope adopts a SaaS-based, centralised method for the disclosure and transparency of clinical trials. This approach has been used by multiple pharmaceutical companies of different sizes.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The alliance with Vivli is expected to help TrialScope deliver a comprehensive platform for disclosure and data sharing.
TrialScope CEO Jeff Kozloff said: “There is a growing trend towards increased transparency within the clinical trial industry, not just to meet regulatory requirements, but as an ethical obligation to advance science and promote patient safety.
“We appreciate the fact that Vivli is disease agnostic and can synthesise data from multiple repositories, which will greatly reduce duplication of clinical trials, putting fewer patients through studies unnecessarily.”
Under the collaboration, the partners will combine their respective expertise to offer disclosure and data sharing software and advisory services.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataIn addition, TrialScope and Vivli intend to provide a technology that will help in finding clinical trial information online. The companies will also deliver end-to-end workflow support for managing data-sharing requests.
Vivli executive director Rebecca Li said: “Together, we offer an end-to-end solution. There is simply no complete solution for researchers and sponsors alike, who want to spend less time searching for previous data, and more time on advancing science.”
Launched last year, Vivli portfolio includes a data sharing platform that currently has more than 3,200 trials across 100 different countries.
